ASX Announcement 24 August 2026 FY 26 Annual Results & Investor Webinar Genetic Signatures [ASX:GSS] (“ GSS ” or “ the Company ”) , a global molecular diagnostics company, will release its FY2026 annual results on Tuesday, 25 August 2026. Following the release of the FY2026...
FY 26 Annual Results and Investor Webinar Notification
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Commercial Testing Commences at Hvidovre Hospital in Denmark
- GSS responds to the BCAL Diagnostics Announcement
- BCAL to Acquire Shares in Genetic Signatures
- Danish Supply Agreement - Additional Information
- Genetic Signatures Signs Danish Supply Agreement
Later from Genetic Signatures
- FY26 Appendix 4E and Annual Report
- FY26 Results Release
- FY26 Appendix 4G and Corporate Governance Statement
- FY26 Market Update
- Change in substantial holding
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures
